Literature DB >> 34231378

M2 macrophages have unique transcriptomes but conditioned media does not promote profibrotic responses in lung fibroblasts or alveolar epithelial cells in vitro.

Elissa M Hult1, Stephen J Gurczynski2, Bethany B Moore2,3.   

Abstract

Macrophages are critical regulators of pulmonary fibrosis. Their plasticity, proximity, and ability to cross talk with structural cells of the lung make them a key cell type of interest in the regulation of lung fibrosis. Macrophages can express a variety of phenotypes, which have been historically represented through an "M1-like" to "M2-like" delineation. In this classification, M1-like macrophages are proinflammatory and have increased phagocytic capacity compared with alternatively activated M2-like macrophages that are profibrotic and are associated with wound healing. Extensive evidence in the field in both patients and animal models aligns pulmonary fibrosis with M2 macrophages. In this study, we performed RNA sequencing (RNAseq) to fully characterize M1- vs. M2-skewed bone marrow-derived macrophages (BMDMs) and investigated the profibrotic abilities of M2 BMDM conditioned media (CM) to promote fibroblast migration and proliferation, alveolar epithelial cell (AEC) apoptosis, and mRNA expression of key fibrotic genes in both fibroblasts and AECs. Although M2 CM-treated fibroblasts had increased migration and M2 CM-treated fibroblasts and AECs had increased expression of profibrotic proteins over M1 CM-treated cells, all differences can be attributed to M2 polarization reagents IL-4 and IL-13 also present in the CM. Collectively, these data suggest that the profibrotic effects associated with M2 macrophage CM in vitro are attributable to effects of polarization cytokines rather than additional factors secreted in response to those polarizing cytokines.

Entities:  

Keywords:  M1/M2 macrophage; RNAseq; alveolar epithelial cell; fibroblast; fibrosis

Mesh:

Substances:

Year:  2021        PMID: 34231378      PMCID: PMC8461801          DOI: 10.1152/ajplung.00107.2021

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  61 in total

1.  Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling.

Authors:  Sergei P Atamas; Irina G Luzina; Heqiao Dai; Susan G Wilt; Barbara White
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  Transcriptome profile of rat genes in bone marrow-derived macrophages at different activation statuses by RNA-sequencing.

Authors:  Xue-Yan Guo; Sai-Nan Wang; Yan Wu; Yu-Hong Lin; Jie Tang; Shu-Qin Ding; Lin Shen; Rui Wang; Jian-Guo Hu; He-Zuo Lü
Journal:  Genomics       Date:  2018-07-06       Impact factor: 5.736

3.  Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.

Authors:  Yang Zhou; Hong Peng; Huanxing Sun; Xueyan Peng; Chuyan Tang; Ye Gan; Xiaosong Chen; Aditi Mathur; Buqu Hu; Martin D Slade; Ruth R Montgomery; Albert C Shaw; Robert J Homer; Eric S White; Chang-Min Lee; Meagan W Moore; Mridu Gulati; Chun Geun Lee; Jack A Elias; Erica L Herzog
Journal:  Sci Transl Med       Date:  2014-06-11       Impact factor: 17.956

Review 4.  Caspases and their substrates.

Authors:  Olivier Julien; James A Wells
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

5.  Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta.

Authors:  Masaki Fujita; John M Shannon; Osamu Morikawa; Jack Gauldie; Nobuyuki Hara; Robert J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2003-06-19       Impact factor: 6.914

6.  Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.

Authors:  Divya Bhatia; Kuei-Pin Chung; Kiichi Nakahira; Edwin Patino; Michelle C Rice; Lisa K Torres; Thangamani Muthukumar; Augustine Mk Choi; Oleh M Akchurin; Mary E Choi
Journal:  JCI Insight       Date:  2019-12-05

7.  FIZZ1 and Ym as tools to discriminate between differentially activated macrophages.

Authors:  Geert Raes; Wim Noël; Alain Beschin; Lea Brys; Patrick de Baetselier; G H G Hassanzadeh
Journal:  Dev Immunol       Date:  2002-09

Review 8.  Chemokine-Induced Macrophage Polarization in Inflammatory Conditions.

Authors:  Pieter Ruytinx; Paul Proost; Jo Van Damme; Sofie Struyf
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

9.  Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.

Authors:  Tuong N Vu; Xuesong Chen; Hussein D Foda; Gerald C Smaldone; Nadia A Hasaneen
Journal:  Respir Res       Date:  2019-09-11

Review 10.  Idiopathic pulmonary fibrosis: pathogenesis and management.

Authors:  Giacomo Sgalla; Bruno Iovene; Mariarosaria Calvello; Margherita Ori; Francesco Varone; Luca Richeldi
Journal:  Respir Res       Date:  2018-02-22
View more
  1 in total

1.  Fibrotic lung disease inhibits immune responses to staphylococcal pneumonia via impaired neutrophil and macrophage function.

Authors:  Helen I Warheit-Niemi; Summer J Edwards; Shuvasree SenGupta; Carole A Parent; Xiaofeng Zhou; David N O'Dwyer; Bethany B Moore
Journal:  JCI Insight       Date:  2022-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.